Securing & Maintaining an Orphan Drug Designation

Time: 9:00 am
day: Day Two

Details:

  • Outlining the most important principles in applying for an EMA orphan designation
  • Understanding how to use data to fulfil the designation criteria, and the importance of maintaining designations by the marketing authorisation phase
  • Highlighting the importance of ‘significant benefit’

Speakers: